Growth Metrics

MediXall (MDXL) Asset Utilization Ratio (2021 - 2024)

MediXall's Asset Utilization Ratio history spans 4 years, with the latest figure at 1.35 for Q3 2024.

  • For Q3 2024, Asset Utilization Ratio rose 172.79% year-over-year to 1.35; the TTM value through Sep 2024 reached 1.35, up 172.79%, while the annual FY2023 figure was 0.58, 879.01% up from the prior year.
  • Asset Utilization Ratio reached 1.35 in Q3 2024 per MDXL's latest filing, up from 1.32 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.48 in Q1 2024 to a low of 0.0 in Q1 2021.
  • Average Asset Utilization Ratio over 4 years is 0.45, with a median of 0.16 recorded in 2022.
  • The largest YoY upside for Asset Utilization Ratio was 9479.94% in 2022 against a maximum downside of 75.53% in 2022.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.14 in 2021, then plummeted by 54.75% to 0.06 in 2022, then soared by 1397.0% to 0.94 in 2023, then surged by 43.73% to 1.35 in 2024.
  • Per Business Quant, the three most recent readings for MDXL's Asset Utilization Ratio are 1.35 (Q3 2024), 1.32 (Q2 2024), and 1.48 (Q1 2024).